CGTN: China monitors coronavirus mutations to adjust COVID-19 response
BEIJING, Jan. 1, 2023 /PRNewswire/ — With China loosening its COVID-19 restrictions, some experts have expressed concern that China’s relaxation
Read MoreBEIJING, Jan. 1, 2023 /PRNewswire/ — With China loosening its COVID-19 restrictions, some experts have expressed concern that China’s relaxation
Read MoreFB2001 (Bofutrelvir) is a Coronavirus Mpro inhibitor, which exhibited potent anti-SARS-CoV-2 activity in vitro and in vivo Phase 1 results
Read More